(Q40337878)
Statements
Predictive factors for outcome in a phase II study of gefitinib in second-line treatment of advanced esophageal cancer patients (English)
Mariëlle I Gallegos-Ruiz
Gerrit A Meijer
Walter L Vervenne
Dick J Richel
Cees Van Groeningen